Paragon 28 acquires Finnish 3D medical imaging company Disior for $18M

Paragon 28, a leading medical device company exclusively focused on the foot and ankle orthopedic market, has announced its acquisition of Disior. This marks significant and exciting news not only for Helsinki-based Disior but also for the Helsinki Metropolitan health ecosystem.

Paragon 28 has announced it has acquired a Finnish medical software company Disior for $18M. Disior, founded in 2016 by Anna-Maria Henell, Gonçalo Barreto, Risto Kontio and Sakari Soini, is specialised in 3D medical imaging of the complex foot and ankle anatomy. The company’s software offers foot and ankle surgeons the objective data needed for delivering perfectly-tailored treatments for every patient.Through the acquisition, Disior will be an integral component to SMART 28™, Paragon’s ecosystem of enabling technologies for pre-operative planning, intra-operative support, and post-operative evaluation.“With this partnership, we have combined our talented teams and will bring a new standard of care to foot and ankle patients,” says Anna-Maria Henell, CEO of Disior.“Bringing Disior in to Smart 28™ is a game changer. We have a unique opportunity with Smart 28 to allow surgeons to connect preoperative planning, intraoperative control and postoperative assessment for their patients”, Disior comments further on LinkedIn.Read our interview with Anna-Maria Henell, CEO of Disior, from 2021:
Disior is transforming 3D medical imaging
From Helsinki Metropolitan health ecosystem

Read more news

Placeholder

News

 Health Capital Helsinki (HCH) invites innovative pharmaceutical companies to join as Founding Pharma Partners. This entry-level partnership offers a way...

18 Dec 2025

Placeholder

News

The festival will bring together Europe’s health innovation ecosystem at Helsinki Expo and Convention Centre for the third time in...

29 Aug 2025

Placeholder

News

How can your health tech startup stay secure in a world of increasing cybersecurity challenges?...

07 Jan 2025

Discover what our partners say about
co-innovation with HCH.